8-K/A: 1847 Holdings Amends 8-K Filing to Restate ICU Eyewear Financials Following Acquisition

1847 Holdings LLC has filed an amendment to its previous 8-K report to restate the financial statements of ICU Eyewear Holdings Inc., which it acquired in February 2023.

Summary

• 1847 Holdings LLC has amended its Form 8-K filing related to the acquisition of ICU Eyewear Holdings Inc.
• The amendment restates ICU Eyewear's financial statements for the years ended December 31, 2022 and 2021.
• The restatement corrects errors in revenue recognition and the impairment of an intangible asset.
• The original acquisition occurred on February 9, 2023, with the initial 8-K filed on February 13, 2023, and a prior amendment on April 27, 2023.
• The audited consolidated financial statements of ICU Eyewear for 2022 and 2021, along with pro forma financial information, are included as exhibits.
• The pro forma financials combine the historical financials of 1847 Holdings and ICU Eyewear as if the acquisition occurred on January 1, 2022 for the statement of operations and December 31, 2022 for the balance sheet.

Sentiment

Score: 4

Explanation: The document reveals a restatement of financials and significant losses, which are negative indicators. However, the acquisition and pro forma statements provide some transparency. The need for potential future capital raises is also a concern.

Positives

• The document provides detailed audited financial statements for ICU Eyewear for 2021 and 2022.
• The pro forma combined financial statements provide a clear picture of the combined entity's financial position and results of operations.
• The document includes a consent from the independent auditors, Frank, Rimerman + Co. LLP, indicating their approval of the financial statements.

Negatives

• ICU Eyewear experienced a net loss of $1,004,651 in 2022.
• The restatement of financial statements indicates prior accounting errors.
• The pro forma combined entity shows a significant net loss of $9,097,550 for 2022.
• ICU Eyewear's revenue decreased from $22,032,654 in 2021 to $20,446,381 in 2022.

Risks

• The restatement of financial statements may raise concerns about the reliability of past financial reporting.
• The combined entity is operating at a loss, which may require additional financing or operational improvements.
• The document mentions that ICU Eyewear may require additional debt or equity financing if it does not generate sufficient revenue.
• The company has a significant accumulated deficit of $32,438,000 at December 31, 2022.
• The company's line of credit expires in April 2024, which may require refinancing or alternative funding.

Future Outlook

Management believes that the acquisition by 1847 Holdings, the forecast of increasing revenue, and the management of operating expenditures will provide sufficient resources to sustain working capital needs through at least February 2, 2025. However, additional debt or equity financing may be required if the company does not generate sufficient revenue.

Management Comments

• Management determined certain adjustments to the 2021 consolidated financial statements were required.
• Management believes it has used reasonable judgments and conclusions in the preparation of its income tax returns.
• Management believes the estimated fair value of any future obligations from indemnification agreements is minimal.
• Management believes the Company was in compliance with all covenants required by the credit facility at December 31, 2022.

Industry Context

The document reflects the ongoing trend of mergers and acquisitions in the market, with 1847 Holdings acquiring ICU Eyewear to expand its portfolio. The restatement of financials highlights the importance of accurate accounting practices in such transactions.

Comparison to Industry Standards

• The restatement of financials is not uncommon in acquisitions, but it does raise questions about the initial due diligence process.
• The pro forma combined financials are a standard practice to show the potential impact of the acquisition on the acquirer's financials.
• The level of detail provided in the audited financial statements is consistent with industry standards for public companies.
• The company's reliance on a single major customer for 65% of its eyewear sales is a risk that is not uncommon in the industry, but it is a point of concern.

Related Party Transactions

• The Company had a distribution and supply agreement with a related-party supplier for personal protective equipment.
• The Company had a major supplier that is a related-party company owned by a stockholder of the Company.

Stakeholder Impact

• Shareholders may be concerned about the restatement of financials and the company's losses.
• Employees may be affected by potential cost-cutting measures or restructuring.
• Customers may be impacted by any changes in the company's operations or product offerings.
• Suppliers may be affected by any changes in the company's purchasing practices.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• The company needs to improve its revenue and manage its expenditures to achieve profitability.
• The company may need to seek additional financing if it does not generate sufficient revenue.
• The company needs to ensure compliance with the covenants of its credit facility.
• The company needs to finalize the accounting for the acquisition of ICU Eyewear.

Key Dates

Keywords

financial statements, acquisition, restatement, pro forma, ICU Eyewear, 1847 Holdings, merger, revenue, net loss, audited